The modulation of CYP7A1 gene expression, which is crucial for the prevention and improvement of hyperlipidemia and atherosclerosis, has been reported to improve these conditions in animal models overexpressing CYP7A1 [4,5]. This evidence concerns the gene CYP7A1 and hyperlipidemia.